Embecta Corp. (EMBC) Notice of August 17, 2026 Deadline in Class Action Lawsuit – Hagens Berman - EMBC

Published August 14, 2026

$5.1

-0.20%

Event

Read full article on globenewswire.com →

About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Stock Price

$5.13

Price Change

+0.00%

More from EMBC

EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - EMBC

August 18, 2026

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - EMBC

August 17, 2026

EMBC Court News: Embecta Securities Fraud Class Action Filed After Insulin Pen Issues and 57% Stock Drop – Contact BFA Law Before August 17 - EMBC

August 17, 2026

Embecta Corp. Sued for Securities Law Violations - FINAL DEADLINE TODAY - EMBC - EMBC

August 17, 2026

Exchange Mix — Recent EMBC Events

NASDAQ

100%

NYSE

AMEX

OTC